President Trump announced the deal during a press conference with the media on Tuesday.
Moderna is one of a number of companies that make “at-risk” vaccines, as the industry calls it, meaning the company is currently making vaccines before they get approved. Clinical trials are currently underway to test whether it is safe and effective.
Under the contract, valued at up to $ 1.525 billion for 100 million doses, these doses will be owned by the US government and will be distributed and used as part of the Covid-19 vaccine campaign. If dosages are used, they are provided free to Americans. HHS said the government could also buy an additional 400 million doses of the vaccine.
The vaccine, called mRNA-1273, was developed by Moderna in collaboration with the US government. It has development assistance from the National Institute of Allergy and Infectious Diseases, and the U.S. Biomedical Progressive Research and Development Agency, known as BARDA, which has supported end-stage clinical trials. and has helped to expand production scale. Moderna’s advanced phase clinical trial, which began July 27, is the first government-sponsored phase 3 clinical trial for Covid-19 vaccine in the United States.
The contract is part of the US government’s Warp Speed Campaign, which pushes the federation to bring vaccines and therapies to the market as soon as possible safely. HHS says the goal is to get the vaccine effective for the American population by the end of the year.
The government also reached an agreement with Pfizer in July to produce 100 million doses of its vaccine. In August, they reached a similar agreement for 100 million doses with Janssen, Johnson & Johnson’s vaccine arm, for its vaccine candidate. It has other deals with GlaxoSmithKline, Sanofi Pasteur, Novavax, and AstraZeneca.
According to the World Health Organization, there are 28 Covid-19 vaccines currently being tested in humans.
“In creating a vaccine portfolio for Operation Warp Speed, the Trump administration is increasing the likelihood that the United States will have at least one safe, effective vaccine by 2021,” HHS Secretary Alex Azar said in a statement. news on Tuesday. “Today’s investment represents the next step in supporting this vaccine candidate throughout the early development process by Moderna and the National Institutes of Health, through clinical trials and now. large-scale production, with the potential to bring hundreds of millions of safe and effective products to the American people. “